• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病患者呼吸困难评估临床方法分析

Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease.

作者信息

Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T

机构信息

Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

出版信息

Am J Respir Crit Care Med. 1998 Oct;158(4):1185-9. doi: 10.1164/ajrccm.158.4.9802091.

DOI:10.1164/ajrccm.158.4.9802091
PMID:9769280
Abstract

When dyspnea must be assessed clinically, there are three methods of assessment: the measurement of dyspnea with activities of daily living using clinical dyspnea ratings such as the modified Medical Research Council (MRC), the Baseline Dyspnea Index (BDI), and the Oxygen Cost Diagram (OCD); the measurement of dyspnea during exercise using the Borg scale; to assess the influence of dyspnea on health-related quality of life (HRQoL) using disease-specific questionnaires such as the St. George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ). The purpose of the present cross-sectional study was to clarify relationships between dyspnea ratings and HRQoL questionnaires by applying factor analysis. One hundred sixty-one patients with mild to severe COPD completed pulmonary function tests, progressive cycle ergometer testing for exercise capacity, assessment of dyspnea, HRQoL, anxiety, and depression. Factor analysis demonstrated that the MRC, BDI, OCD, and Activity of the SGRQ, and Dyspnea of the CRQ, were grouped into the same factor, and the frequency distribution histograms of these five measures showed virtually the same distribution. The Borg scale at the end of maximum exercise was found to be a different factor. The MRC, BDI, OCD, and Activity in the SGRQ, and Dyspnea in the CRQ demonstrated the same pattern of correlation with physiologic data, and they had significant relationships with FEV1 (correlation coefficients [Rs] = 0.31 to 0. 48) and maximal oxygen uptake (Rs = 0.46 to 0.60). Disease-specific HRQoL questionnaires, the SGRQ and the CRQ, which contain a specific dimension for evaluating dyspnea, may be substituted for clinical dyspnea ratings in a cross-sectional assessment. Dyspnea rating at the end of exercise may provide further information regarding dyspnea.

摘要

当必须通过临床手段评估呼吸困难时,有三种评估方法:使用改良医学研究委员会(MRC)、基线呼吸困难指数(BDI)和氧耗图(OCD)等临床呼吸困难分级,测量日常生活活动中的呼吸困难;使用博格量表测量运动期间的呼吸困难;使用圣乔治呼吸问卷(SGRQ)和慢性呼吸系统疾病问卷(CRQ)等疾病特异性问卷评估呼吸困难对健康相关生活质量(HRQoL)的影响。本横断面研究的目的是通过应用因子分析来阐明呼吸困难分级与HRQoL问卷之间的关系。161例轻至重度慢性阻塞性肺疾病(COPD)患者完成了肺功能测试、用于评估运动能力的递增式循环测力计测试、呼吸困难评估、HRQoL评估、焦虑和抑郁评估。因子分析表明,MRC、BDI、OCD以及SGRQ的活动部分和CRQ的呼吸困难部分被归为同一因子,这五项指标的频率分布直方图显示出几乎相同的分布。发现最大运动结束时的博格量表属于另一个因子。MRC、BDI、OCD以及SGRQ的活动部分和CRQ的呼吸困难部分与生理数据呈现相同的相关模式,并且它们与第一秒用力呼气容积(FEV1)(相关系数[Rs]=0.31至0.48)和最大摄氧量(Rs=0.46至0.60)具有显著相关性。包含评估呼吸困难特定维度的疾病特异性HRQoL问卷SGRQ和CRQ,在横断面评估中可替代临床呼吸困难分级。运动结束时的呼吸困难分级可能会提供有关呼吸困难的更多信息。

相似文献

1
Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者呼吸困难评估临床方法分析
Am J Respir Crit Care Med. 1998 Oct;158(4):1185-9. doi: 10.1164/ajrccm.158.4.9802091.
2
Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease.用于测量慢性阻塞性肺疾病患者健康相关生活质量的疾病特异性问卷之间的鉴别特性比较。
Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):785-90. doi: 10.1164/ajrccm.157.3.9703055.
3
A novel, short, and simple questionnaire to measure health-related quality of life in patients with chronic obstructive pulmonary disease.一种用于测量慢性阻塞性肺疾病患者健康相关生活质量的新颖、简短且简单的问卷。
Am J Respir Crit Care Med. 1999 Jun;159(6):1874-8. doi: 10.1164/ajrccm.159.6.9807097.
4
Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的疾病严重程度阶段及影响其健康状况的因素。
Respir Med. 2000 Sep;94(9):841-6. doi: 10.1053/rmed.2000.0804.
5
Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study.慢性阻塞性肺疾病患者呼吸困难的纵向变化分析:一项观察性研究。
Respir Res. 2012 Sep 25;13(1):85. doi: 10.1186/1465-9921-13-85.
6
The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease.BODE 指数与慢性阻塞性肺疾病患者生活质量的横断面和纵向关联。
Chin Med J (Engl). 2009 Dec 20;122(24):2939-44.
7
American translation, modification, and validation of the St. George's Respiratory Questionnaire.圣乔治呼吸问卷的美国版翻译、修改及验证
Clin Ther. 2000 Sep;22(9):1121-45. doi: 10.1016/S0149-2918(00)80089-2.
8
A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者呼吸困难评分、呼吸肌力量和肺功能的因素分析。
Am Rev Respir Dis. 1992 Feb;145(2 Pt 1):467-70. doi: 10.1164/ajrccm/145.2_Pt_1.467.
9
Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.改良医学研究委员会量表与基线呼吸困难指数用于评估慢性阻塞性肺疾病中的呼吸困难
Int J Chron Obstruct Pulmon Dis. 2015 Aug 18;10:1663-72. doi: 10.2147/COPD.S82408. eCollection 2015.
10
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.医学研究委员会(MRC)呼吸困难量表在评估慢性阻塞性肺疾病患者残疾程度方面的实用性。
Thorax. 1999 Jul;54(7):581-6. doi: 10.1136/thx.54.7.581.

引用本文的文献

1
A complicated case of relapsing polychondritis: Case report.复发性多软骨炎复杂病例:病例报告
Medicine (Baltimore). 2025 Jun 20;104(25):e42987. doi: 10.1097/MD.0000000000042987.
2
The desat-max in 2-chair test appears to be a worthwhile parameter to identify sickness: An appraisal.双椅试验中的最大去饱和度似乎是一个用于识别疾病的有价值参数:一项评估。
Indian J Med Res. 2025 Feb;161(2):174-181. doi: 10.25259/IJMR_952_2024.
3
User-centred design of ChestCare: mHealth app for pulmonary rehabilitation for patients with COPD; a mixed-methods sequential approach.
以患者为中心的ChestCare设计:用于慢性阻塞性肺疾病患者肺康复的移动健康应用程序;一种混合方法的序贯研究方法。
Digit Health. 2025 Jan 17;11:20552076241307476. doi: 10.1177/20552076241307476. eCollection 2025 Jan-Dec.
4
Incident Cardiometabolic Comorbidities in Smokers with/Without Chronic Obstructive Pulmonary Disease: A Long-Term Cohort Study.患有/未患有慢性阻塞性肺疾病的吸烟者的心血管代谢共病事件:一项长期队列研究。
J Clin Med. 2024 Dec 14;13(24):7627. doi: 10.3390/jcm13247627.
5
Clinical implications of the SERPINA1 variant, M, and alpha-1 antitrypsin deficiency in Türkiye.丝氨酸蛋白酶抑制剂A1(SERPINA1)变体M及α-1抗胰蛋白酶缺乏症在土耳其的临床意义。
BMC Pulm Med. 2024 Dec 18;24(1):622. doi: 10.1186/s12890-024-03421-y.
6
Obesity Impact on Dyspnea in COPD Patients.肥胖对 COPD 患者呼吸困难的影响。
Int J Chron Obstruct Pulmon Dis. 2024 Jul 22;19:1695-1706. doi: 10.2147/COPD.S450366. eCollection 2024.
7
Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort.他汀类药物并未降低 COPD 合并心血管合并症患者在 COSYCONET 队列中的恶化频率。
Respir Res. 2024 May 15;25(1):207. doi: 10.1186/s12931-024-02822-1.
8
Clinical Burden of Chronic Obstructive Pulmonary Disease in Patients with Suboptimal Peak Inspiratory Flow.未达最佳峰吸气流速的慢性阻塞性肺疾病患者的临床负担。
Can Respir J. 2024 Mar 22;2024:8034923. doi: 10.1155/2024/8034923. eCollection 2024.
9
The modified Medical Research Council scale misclassifies exertional breathlessness among people referred for exercise testing.改良的医学研究委员会量表会将转诊进行运动测试的人群中的运动性呼吸困难误分类。
ERJ Open Res. 2023 Dec 27;9(6). doi: 10.1183/23120541.00592-2023. eCollection 2023 Nov.
10
Value of cardiopulmonary exercise testing in the assessment of symptoms and quality of life in Asian patients with chronic obstructive pulmonary disease.心肺运动试验在评估亚洲慢性阻塞性肺疾病患者症状及生活质量中的价值
J Thorac Dis. 2023 Jul 31;15(7):3662-3672. doi: 10.21037/jtd-23-185. Epub 2023 Jul 18.